Akita, H., Takahashi, H., Eguchi, H., Asukai, K., Hasegawa, S., Wada, H., . . . Sakon, M. (2020). Difference between carbohydrate antigen 19‐9 and fluorine‐18 fluorodeoxyglucose positron emission tomography in evaluating the treatment efficacy of neoadjuvant treatment in patients with resectable and borderline resectable pancreatic ductal adenocarcinoma: Results of a dual‐center study. Ann Gastroenterol Surg.
Chicago Stili AlıntıAkita, Hirofumi, et al. "Difference between Carbohydrate Antigen 19‐9 and Fluorine‐18 Fluorodeoxyglucose Positron Emission Tomography in Evaluating the Treatment Efficacy of Neoadjuvant Treatment in Patients With Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma: Results of a Dual‐center Study." Ann Gastroenterol Surg 2020.
MLA AlıntıAkita, Hirofumi, et al. "Difference between Carbohydrate Antigen 19‐9 and Fluorine‐18 Fluorodeoxyglucose Positron Emission Tomography in Evaluating the Treatment Efficacy of Neoadjuvant Treatment in Patients With Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma: Results of a Dual‐center Study." Ann Gastroenterol Surg 2020.